Methoxetamine: Difference between revisions
>Oskykins |
>Surgeon Implemented template |
||
Line 1: | Line 1: | ||
{| | {{Substance | ||
|name=Methoxetamine | |||
| | |abbreviation=MXE | ||
| | |IUPAC=(RS)2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone | ||
|img-skel=Image:Mxe.png | |||
|img-3d=Methoxetamine 3d.gif | |||
|dosage-insufflated-threshold=5 - 20 mg | |||
|dosage-insufflated-light=10 - 50 mg | |||
| | |dosage-insufflated-common=30 - 75 mg | ||
|dosage-insufflated-strong=60 - 125 mg | |||
|dosage-insufflated-hole=100 - 250 mg | |||
|- | |duration-total=3 - 5 hrs | ||
|duration-onset=10 - 20 mins | |||
|- | |duration-coming-up=15 - 30 mins | ||
|duration-peak=60 - 120 mins | |||
|- | |duration-coming-down=60 - 120 mins | ||
}} | |||
|- | |||
|- | |||
|- | |||
|- | |||
|- | |||
|- | |||
'''Methoxetamine (MXE)''' or '''3-MeO-2-Oxo-PCE''' is a chemical of the [[arylcyclohexylamines|arylcyclohexylamine]] class which acts as an [[Dissociatives#Mechanism_of_Action|NMDA Receptor Antagonist]], [[dopamine]]-[[Reuptake Inhibitor|reuptake inhibitor]] and a [[serotonin]] reuptake inhibitor with µ-opioid affinity and typical [[Dissociatives#Subjective effects|dissociative]] effects. | '''Methoxetamine (MXE)''' or '''3-MeO-2-Oxo-PCE''' is a chemical of the [[arylcyclohexylamines|arylcyclohexylamine]] class which acts as an [[Dissociatives#Mechanism_of_Action|NMDA Receptor Antagonist]], [[dopamine]]-[[Reuptake Inhibitor|reuptake inhibitor]] and a [[serotonin]] reuptake inhibitor with µ-opioid affinity and typical [[Dissociatives#Subjective effects|dissociative]] effects. |